Drugs / CMV-Ig
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00137748 | Jan 2001 → Jan 2006 | dysgammaglobulinemia | The Cleveland Clinic | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMV-Ig | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00137748 ↗ |